272 related articles for article (PubMed ID: 29705529)
21. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Kondili LA; Monti M; Quaranta MG; Gragnani L; Panetta V; Brancaccio G; Mazzaro C; Persico M; Masarone M; Gentile I; Andreone P; Madonia S; Biliotti E; Filomia R; Puoti M; Fracanzani AL; Laccabue D; Ieluzzi D; Coppola C; Rumi MG; Benedetti A; Verucchi G; Coco B; Chemello L; Iannone A; Ciancio A; Russo FP; Barbaro F; Morisco F; Chessa L; Massari M; Blanc P; Zignego AL
Hepatology; 2022 Jul; 76(1):220-232. PubMed ID: 34919289
[TBL] [Abstract][Full Text] [Related]
22. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
Roccatello D; Fenoglio R; Sciascia S
Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
[TBL] [Abstract][Full Text] [Related]
23. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
24. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
26. [Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment].
Ignatova TM; Kozlovskaya LV; Gordovskaya NB; Chernova OA; Milovanova SY; Novikov PI; Nekrasova TP; Beketova TV; Mukhin NA
Ter Arkh; 2017; 89(5):46-52. PubMed ID: 28631698
[TBL] [Abstract][Full Text] [Related]
27. Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.
Gragnani L; Cerretelli G; Lorini S; Steidl C; Giovannelli A; Monti M; Petraccia L; Sadalla S; Urraro T; Caini P; Xheka A; Simone A; Arena U; Matucci-Cerinic M; Vergani D; Laffi G; Zignego AL
Aliment Pharmacol Ther; 2018 Aug; 48(4):440-450. PubMed ID: 29952013
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Cryoglobulinemias.
Fuentes A; Mardones C; Burgos PI
Curr Rheumatol Rep; 2019 Nov; 21(11):60. PubMed ID: 31741077
[TBL] [Abstract][Full Text] [Related]
29. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
30. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
31. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
[TBL] [Abstract][Full Text] [Related]
32. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
33. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
34. Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
Zignego AL; Marri S; Gragnani L
Minerva Gastroenterol (Torino); 2021 Sep; 67(3):218-226. PubMed ID: 33793154
[TBL] [Abstract][Full Text] [Related]
35. Cryoglobulinemia.
Tedeschi A; Baratè C; Minola E; Morra E
Blood Rev; 2007 Jul; 21(4):183-200. PubMed ID: 17289231
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals.
Comarmond C; Cacoub P; Saadoun D
Therap Adv Gastroenterol; 2020; 13():1756284820942617. PubMed ID: 32782479
[TBL] [Abstract][Full Text] [Related]
37. Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate.
Napodano C; Ciasca G; Chiusolo P; Pocino K; Gragnani L; Stefanile A; Gulli F; Lorini S; Minnella G; Fosso F; Di Santo R; Romanò S; Basile V; De Stefano V; Rapaccini GL; Zignego AL; Di Stasio E; Marino M; Basile U
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511357
[TBL] [Abstract][Full Text] [Related]
38. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.
Quartuccio L; Isola M; Corazza L; Maset M; Monti G; Gabrielli A; Tzioufas AG; Ferri C; Ferraccioli G; Ramos-Casals M; Voulgarelis M; Lenzi M; Mascia MT; Sansonno D; Cacoub P; Tomsic M; Tavoni A; Pietrogrande M; Zignego AL; Scarpato S; Pioltelli P; Steinfeld S; Lamprecht P; Galli M; Bombardieri S; De Vita S
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S48-52. PubMed ID: 22410397
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
[TBL] [Abstract][Full Text] [Related]
40. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
Gragnani L; Lorini S; Marri S; Vacchi C; Madia F; Monti M; Ferri C; Zignego AL
Autoimmun Rev; 2022 Jan; 21(1):102923. PubMed ID: 34419670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
